Direkt zum Inhalt
Merck

Fortfahren mit

I1782

Inosine Monophosphate Dehydrogenase Type II human

recombinant, expressed in E. coli

Synonym(e):

IMP:NAD oxidoreductase, IMPDH II

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
Größe/SKUVerfügbarkeitPreis
0.125 mL
Warenkorb auf Verfügbarkeit prüfen
€ 792,00

Über diesen Artikel

UNSPSC Code:
12352204
NACRES:
NA.54
EG-Nummer:
MDL number:
Specific activity:
≥0.05 units/mg protein
Recombinant:
expressed in E. coli

€ 792,00


Warenkorb auf Verfügbarkeit prüfen

​
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


recombinant

expressed in E. coli

Quality Segment

form

solution

specific activity

≥0.05 units/mg protein

mol wt

~55 kDa

packaging

vial of ≥0.002 unit

UniProt accession no.

relevant disease(s)

cancer

shipped in

dry ice

storage temp.

−70°C

Gene Information

human ... IMPDH2(3615)

General description

Inosine Monophosphate Dehydrogenase Type II (IMPDH2) is a ubiquitously expressed dominant isoform during developmental stages. IMPDH2 gene is mapped to human chromosome 3p21.31.

Application

Inosine Monophosphate Dehydrogenase Type II human has been used to test the inhibitory effect on vacor adenine dinucleotide (VAD) on its dehydrogenase activity.

Biochem/physiol Actions

Inosine Monophosphate Dehydrogenase Type II (IMPDH2) binds to adenosine triphosphate (ATP) and guanosine triphosphate (GTP). It catalyzes the formation of xanthosine monophosphate from inosine monophosphate in the presence of nicotinamide adenine dinucleotide (NAD). IMPDH2 elevated levels in tumors are correlated to its rate-limiting activity in guanosine monophosphate (GMP) synthesis. High levels of IMPDH2 is implicated in glioblastoma (GBM). It is regarded as a potential therapeutic target against tumors, antiviral, and immunosuppression-related pathologies.
Type II is the predominant IMPDH isoform and is specifically linked to a wide range of cancers and lymphocyte proliferation.

Physical form

Solution in 20 mM Tris-HCl, pH 8.0, containing 0.5 mM EDTA and 1 mM DTT.

Other Notes

One unit will produce 1.0 μ mole of XMP from IMP with corresponding reduction of β-NAD per minute at pH 8.0 at 25 °C.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
ST1578I5036SRE0024
description

recombinant, expressed in E. coli

description

liquid, clone 1E12-B6, Calbiochem®

description

recombinant, expressed in E. coli, lyophilized powder, ≥80 units/mg protein

description

recombinant, expressed in Escherichia coli

Gene Information

human ... IMPDH2(3615)

Gene Information

human ... IMPDH2(3615)

Gene Information

-

Gene Information

-

specific activity

≥0.05 units/mg protein

specific activity

-

specific activity

≥80 units/mg protein

specific activity

≥80 units/mg protein

recombinant

expressed in E. coli

recombinant

-

recombinant

expressed in E. coli

recombinant

expressed in E. coli

form

solution

form

liquid

form

lyophilized powder

form

-

mol wt

~55 kDa

mol wt

-

mol wt

46,658 Da

mol wt

-

UniProt accession no.

P12268

UniProt accession no.

-

UniProt accession no.

-

UniProt accession no.

-


Lagerklasse

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen



Questions

Reviews

No rating value

Active Filters